PubMed Mentions
The links below are to publications on PubMed referring to PDBP: Parkinson's Disease Biomarkers Program. This list is gathered weekly from PubMed automatically.
| Publication/References | |
| Evaluation of RNA Blood Biomarkers in the Parkinson's Disease Biomarkers Program. Description: Santiago, Jose A, et al. Evaluation of RNA Blood Biomarkers in the Parkinson's Disease Biomarkers Program. ''Front Aging Neurosci''. 2018; '''10''': 157 | |
| A single nucleotide polymorphism in dopamine beta hydroxylase (rs6271(C>T)) is over-represented in inflammatory bowel disease patients and reduces circulating enzyme. Description: Gonzalez-Lopez, Eugene, et al. A single nucleotide polymorphism in dopamine beta hydroxylase (rs6271(C>T)) is over-represented in inflammatory bowel disease patients and reduces circulating enzyme. ''PLoS One''. 2019; '''14''' (2):e0210175 | |
| Development of an informatics system for accelerating biomedical research. Description: Navale, Vivek, et al. Development of an informatics system for accelerating biomedical research. ''F1000Res''. 2019; '''8''': 1430 | |
| Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts. Description: Iwaki, Hirotaka, et al. Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts. ''Neurol Genet''. 2019 Aug; '''5''' (4):e348 | |
| Bringing radiomics into a multi-omics framework for a comprehensive genotype-phenotype characterization of oncological diseases. Description: Zanfardino, Mario, et al. Bringing radiomics into a multi-omics framework for a comprehensive genotype-phenotype characterization of oncological diseases. ''J Transl Med''. 2019 Oct 7; '''17''' (1):337 | |
| Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease. Description: Bandres-Ciga, S, et al. Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease. ''Acta Neuropathol''. 2020 Sep; '''140''' (3):341-358 | |
| Differential blood DNA methylation across Lewy body dementias. Description: Nasamran, Chanond A, et al. Differential blood DNA methylation across Lewy body dementias. ''Alzheimers Dement (Amst)''. 2021; '''13''' (1):e12156 | |
| Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD). Description: Schneider, Ruth B, et al. Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD). ''Ann Clin Transl Neurol''. 2021 Feb; '''8''' (2):308-320 | |
| Assessment of LIN28A variants in Parkinson's disease in large European cohorts. Description: Diez-Fairen, Monica, et al. Assessment of LIN28A variants in Parkinson's disease in large European cohorts. ''Neurobiol Aging''. 2021 Apr; '''100''': 118.e1-118.e3 | |
| Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease. Description: Liu, Ganqiang, et al. Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease. ''Nat Genet''. 2021 Jun; '''53''' (6):787-793 | |
| Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource. Description: Iwaki, Hirotaka, et al. Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource. ''Mov Disord''. 2021 Aug; '''36''' (8):1795-1804 | |
| Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Description: Mitchell, Trina, et al. Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. ''Neuroimage Clin''. 2022 Apr 26; '''34''': 103022 | |
| Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease. Description: Wang, Shijie, et al. Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease. ''Mov Disord''. 2022 Jul; '''37''' (7):1454-1464 | |
| Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson's disease and atypical parkinsonism. Description: Wilkes, Bradley J, et al. Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson's disease and atypical parkinsonism. ''NPJ Parkinsons Dis''. 2023 Jun 5; '''9''' (1):85 | |
| Federated Learning for multi-omics: a performance evaluation in Parkinson's disease. Description: Danek, Benjamin, et al. Federated Learning for multi-omics: a performance evaluation in Parkinson's disease. ''bioRxiv''. 2023 Oct 6; | |
| Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA. Description: De Francesco, Silvia, et al. Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA. ''Sci Rep''. 2023 Oct 13; '''13''' (1):17355 | |
| DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease. Description: Appleton, Ellen, et al. DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease. ''Transl Neurodegener''. 2024 Jun 11; '''13''' (1):31 | |
| Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation. Description: Yuan, Yuan, et al. Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation. ''Mol Neurodegener''. 2024 Jun 11; '''19''' (1):47 | |
| Identification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data. Description: Su, Chang, et al. Identification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data. ''NPJ Digit Med''. 2024 Jul 9; '''7''' (1):184 | |
| Increased burden of rare risk variants across gene expression networks predisposes to sporadic Parkinson's disease. Description: Eubanks, Elena, et al. Increased burden of rare risk variants across gene expression networks predisposes to sporadic Parkinson's disease. ''bioRxiv''. 2024 Sep 1; | |
| Peripheral immune cell abundance differences link blood mitochondrial DNA copy number and Parkinson's disease. Description: Wang, Longfei, et al. Peripheral immune cell abundance differences link blood mitochondrial DNA copy number and Parkinson's disease. ''NPJ Parkinsons Dis''. 2024 Nov 14; '''10''' (1):219 | |
| Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathology and Progression. Description: Higginbotham, Lenora, et al. Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathology and Progression. ''bioRxiv''. 2025 Jun 13; | |
| Impact of Y chromosome loss on the risk of Parkinson's disease and progression. Description: Wang, Junhao, et al. Impact of Y chromosome loss on the risk of Parkinson's disease and progression. ''EBioMedicine''. 2025 Jul; '''117''': 105769 |